Dr. Arkadiusz Dudek
Dr. Arkadiusz Dudek not only has a medical degree with a specialty in mesothelioma treatment, but he also holds a doctorate degree, the highest academic degree that can be earned at any university.
There is no doubt that Dr. Dudek has focused his life on learning and helping patients who are suffering from a variety of cancers, including mesothelioma. He has concentrated his work on medical oncology, immunotherapy, lung cancer and mesothelioma.
Today, Dr. Dudek is a professor of medicine at the University of Illinois’ division of hematology and oncology. He is also the medical director of clinical trials at the university’s cancer center.
Connect with Top Doctors and Cancer Centers
Get help connecting with a mesothelioma doctor or treatment center near you right now!
What is Dr. Dudek’s Specialty
Dr. Dudek’s clinical practice focuses on kidney and lung cancers and melanomas. He is world renowned for his work in renal cell carcinomas and thoracic cancers, among other types of cancer.
For his research, his interests include immunotherapy, targeted therapy and tumor angiogenesis, which is the tumor’s ability to stimulate the growth of new blood vessels. He’s been working toward developing phase I cancer clinical trials.
Dr. Dudek was born, raised and educated in Warsaw, Poland. In 1989, he received his M.D. While in Poland, he also earned his Ph.D. from the Military Medical Academy of Warsaw.
After moving to the United States, he completed his internal medical residency in 1994 at the Polyclinic Medical Center in Pennsylvania. He also completed clinical rotations in a variety of specialties including bone marrow transplantation.
Dr. Dudek served his fellowship in medical oncology and hematology at the University of Minnesota's department of medicine. While there, his research focused on blood and bone marrow transplantation. He also experimented with chemotherapy for late-term mesothelioma patients. While in Minnesota, he served on the Biothera Clinical Advisory Board to help with the efforts to create new cancer medications.
In the years that followed, Dr. Dudek became known for his groundbreaking research in several areas of oncology. He has become known as a mentor to researchers and physicians from around the world.
Currently, Dr.Dudek is continuing his work at the University of Illinois, where he is focusing on cancer angiogenesis, cancer microenvironment and tumor vaccines, just to name a few. His research includes a phase II study of the cancer-treatment drug Dasatinib in patients with previously treated mesothelioma. He sits on the board of directors for the A Breath of Hope Lung Foundation. Dudek speaks Polish, Russian and English.
Biothera Expands Clinical Advisory Board. Reuters. Retrieved from http://www.reuters.com/article/2008/12/11/idUS168845+11-Dec-2008+BW20081211
University of Illinois Hospital & Health Sciences Systems. Our New Physicians at UI Health. http://hospital.uillinois.edu/Find_a_Doctor/Our_New_Physicians.html